Lori Christman

Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma

Vernon K. Sondak, Dennis W. King, Jonathan S. Zager et al. · Annals of Surgical Oncology · 2012 · 145 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

[99mTc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial

Amit Agrawal, Francisco Civantos, Kevin T. Brumund et al. · Annals of Surgical Oncology · 2015 · 132 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials

Anne M. Wallace, Linda K. Han, Stephen P. Povoski et al. · Annals of Surgical Oncology · 2013 · 113 citations · Full text

Medicine, Oncology, Surgery +17

Prospective, Double-Blind, Randomized Study to Evaluate Single-Injection Adductor Canal Nerve Block Versus Femoral Nerve Block

George I. Macrinici, Carol Murphy, Lori Christman et al. · Regional Anesthesia & Pain Medicine · 2016 · 44 citations

Medicine, Orthopaedic Surgery, Surgery +17

A multiplex serum protein assay for determining the probability of colorectal cancer.

Randall Brock, Bob Xiong, Lily Li et al. · PubMed · 2012 · 23 citations

Life Sciences, Biochemistry, Oncology +17